Cleared Traditional

K851369 - ANTINUCLEAR ANTIBODY TEST KIT

K851369 is an FDA 510(k) clearance for ANTINUCLEAR ANTIBODY TEST KIT, manufactured by Modern Diagnostics, Inc.. The device is a Class 2 Immunology device with product code DHN cleared through the Traditional 510(k) pathway after a 40-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1985
Decision
40d
Days
Class 2
Risk

K851369 is an FDA 510(k) clearance for the ANTINUCLEAR ANTIBODY TEST KIT. Classified as Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control (product code DHN), Class II - Special Controls.

Submitted by Modern Diagnostics, Inc. (Sacramento, US). The FDA issued a Cleared decision on May 15, 1985 after a review of 40 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5100 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K851369

510(k) Number K851369 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 05, 1985
Decision Date May 15, 1985
Days to Decision 40 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
65d faster than avg
Panel avg: 105d · This submission: 40d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DHN Device Classification - Class 2, Special Controls

Product Code DHN Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DHN Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control

All 109
Devices cleared under the same product code (DHN) and FDA review panel - the closest regulatory comparables to K851369.
AFT-HEP SYSTEM
K860183 · Behring Diagnostics, Inc. · Feb 1986
FANA 60
K854314 · American Bio-Reagents, Inc. · Dec 1985
SS-A(RO) & SS-B(LA) ANTIBODY ASSAY
K852033 · Meloy Laboratories, Inc. · Jun 1985
AUTOFLUOR V SYSTEM
K842991 · Tech America Diagnostics · Mar 1985
MELOY LAB-ANTINUCLEAR ANTIBODY TEST-HEP-2 CELL CUL
K844678 · Meloy Laboratories, Inc. · Jan 1985
AUTOFLOUR III SYSTEM
K841984 · Tech America Diagnostics · Nov 1984